Skip to content
Research/Bioregulators/Cardiogen

Cardiogen

Synthetic cardiac bioregulator targeting heart muscle. Supports myocardial function and cardiovascular health. Sequence: Ala-Glu-Asp-Arg.

Intelligence Profile

Science

Based on the evidence provided, I cannot determine the mechanism of action for "Cardiogen" at the molecular or physiological level.

The PubMed search results focus primarily on transthyretin cardiac amyloidosis, genetic counseling for cardiomyopathies, and other cardiac conditions, but do not contain any studies specifically investigating how Cardiogen works mechanistically.

The only relevant finding is a single clinical trial (NCT01424774) that mentions "CardioGen-82 PET MPI Scanning" in its title. However, this appears to reference CardioGen-82 (rubidium-82), which is a different compound used as a radiotracer for cardiac PET imaging, not the "Cardiogen" compound in question. Additionally, this trial was focused on evaluating strontium exposure after PET scanning rather than investigating Cardiogen's mechanism of action.

Evidence limitation: The current evidence base does not provide sufficient information to describe how Cardiogen works at the molecular or physiological level. Additional research specifically examining this compound's mechanism of action would be needed to provide an accurate scientific explanation.

Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment.